公开(公告)号：EP4151198A1

公开(公告)日：2023-03-22

申请号：EP21804042.6

申请日：2021-05-14

Applicant: OSAKA UNIVERSITY

Inventor： KATO Hiroki ,  FUKASE Koichi ,  KABAYAMA Kazuya ,  SHIMOYAMA Atsushi ,  KADONAGA Yuichiro ,  TOYOSHIMA Atsushi ,  SHINOHARA Atsushi ,  KANEDA Yasufumi ,  NISHIKAWA Tomoyuki

IPC: A61K20060101

Abstract: The present invention relates to a gold nanoparticle-containing medicine, and a treatment of a proliferative disease using the medicine. The present invention also relates to a gold nanoparticle-containing medicine that is bound to an alpha radioactive nucleus, and a treatment of a proliferative disease using the medicine.

公开(公告)号：EP3560505A1

公开(公告)日：2019-10-30

申请号：EP17877435.2

申请日：2017-12-06

Applicant: Osaka University ,  Foundation for Biomedical Research and Innovation At Kobe ,  GenomIdea Inc.

Inventor： KANEDA Yasufumi ,  FUKUSHIMA Masanori ,  NAKAJIMA Toshihiro

IPC: A61K35/76 ,  A61K39/395 ,  A61K45/00 ,  A61P3/10 ,  A61P9/00 ,  A61P21/00 ,  A61P25/00 ,  A61P25/16 ,  A61P25/28 ,  A61P27/02 ,  A61P43/00

Abstract: The present invention relates to a medicament for preventing and/or treating cognitive impairment and/or a neurodegenerative disease with accumulation of a prionoid, comprising a Sendai virus envelope as an active ingredient and combined application of the medicament and an immune checkpoint inhibitor.